title: Secondary non-response due to development of neutralising antibodies to botulinum toxin A during treatment of children with cerebral palsy.
authors.forename: J
authors.initials: J
authors.lastname: Herrmann
authors.forename: V
authors.initials: V
authors.lastname: Mall
authors.forename: H
authors.initials: H
authors.lastname: Bigalke
authors.forename: K
authors.initials: K
authors.lastname: Geth
authors.forename: R
authors.initials: R
authors.lastname: Korinthenberg
authors.forename: F
authors.initials: F
authors.lastname: Heinen
mesh_terms: D000293:Adolescent; D000917:Antibody Formation; D019274:Botulinum Toxins, Type A / Q000276:immunology* / Q000494:pharmacology*; D002547:Cerebral Palsy / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D004351:Drug Resistance; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D009465:Neuromuscular Agents / Q000276:immunology* / Q000494:pharmacology*
chemical_list: D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A